REPLIGEN CORP — Director's Dealing 2022

Aug 12, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2022-08-11

Reporting Person: KURIYEL RALF (Senior VP, R&D)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-11	Common Stock	M	2000	$33.05	Acquired	22110	Direct
2022-08-11	Common Stock	M	1354	$59.52	Acquired	23464	Direct
2022-08-11	Common Stock	M	646	$86.10	Acquired	24110	Direct
2022-08-11	Common Stock	S	800	$255.20	Disposed	23310	Direct
2022-08-11	Common Stock	S	4040	$254.14	Disposed	19270	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-11	Stock Option (Right to Buy)	$33.05	M	2000	Acquired	2026-12-14	Common Stock (2000)	Direct
2022-08-11	Stock Option (Right to Buy)	$59.52	M	1354	Acquired	2029-02-28	Common Stock (1354)	Direct
2022-08-11	Stock Option (Right to Buy)	$86.10	M	646	Acquired	2027-02-23	Common Stock (646)	Direct

Footnotes

F1: $254.14 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $254.10 to $254.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F2: This option is fully vested and exercisable.

F3: 1,046 shares vest and become exercisable on 2/27/2023.